AI Science Tracker
EN

Asthma Exacerbation Prediction and Risk Factor Analysis Based on a Time-Sensitive, Attentive Neural Network: Retrospective Cohort Study.

The University of Texas Health Science Center at Houston · 31 Jul 2020 · medicine

Discovery

Asthma Exacerbation Prediction and Risk Factor Analysis Based on a Time-Sensitive, Attentive Neural Network: Retrospective Cohort Study.

Source check: Source checked. Not independent scientific confirmation.

Finding: The JMIR article reports a time-sensitive attentive neural network for asthma-exacerbation prediction in 31,433 adults, with five-fold cross-validation and patient/cohort-level factor analysis. The paper appeared in Journal of Medical Internet Research. Organization is unavailable in the deposited bibliographic metadata.

Technology: Time-sensitive attentive neural network for asthma exacerbation prediction

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
The learned network models temporal EHR variables and attention-based risk factors.
Test and result
The JMIR article reports a time-sensitive attentive neural network for asthma-exacerbation prediction in 31,433 adults, with five-fold cross-validation and patient/cohort-level factor analysis.
Limitation / still unknown
The reviewed study does not establish validation or benefit beyond its reported evaluation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.jmir.org/2020/7/e16981/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.